Fig. 2From: Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in SwedenTreatment sequences for metastatic breast cancer patients: HER2/Luminal, HER2/ER–, TNBC; and, Unclassified. Treatment sequences for metastatic breast cancer patients: HER2/Luminal all patients (A); HER2/ ER– all patients (B); TNBC all patients (C); and, Unclassified (D), where HER = human epidermal growth factor receptor 2; ER– = estrogen receptor-negative; and, TNBC = triple negative breast cancerBack to article page